Company Imunosim Medical Srl with Fiscal Code 30049332
recorded a turnover of 2024 of
150.102,
with a net profit of
67.519
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al altor produse alimentare having the NACE code 4727.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Imunosim Medical Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
0
1.314
26.039
59.350
38.456
76.285
119.521
156.881
150.102
Total Income - EUR
0
0
1.314
26.039
59.350
38.456
76.285
119.521
156.881
150.109
Total Expenses - EUR
191
0
1.892
13.511
21.857
16.894
35.404
62.611
80.657
79.283
Gross Profit/Loss - EUR
-191
0
-579
12.528
37.493
21.562
40.880
56.911
76.224
70.826
Net Profit/Loss - EUR
-191
0
-619
11.747
35.712
20.408
38.866
53.755
74.655
67.519
Employees
0
0
0
1
1
1
1
0
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -3.8%, from 156.881 euro in the year 2023, to 150.102 euro in 2024.
The Net Profit decreased by -6.719 euro, from 74.655 euro in 2023, to 67.519 in the last year.
Check the financial reports for the company - Imunosim Medical Srl
Financial Rating - IMUNOSIM MEDICAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Imunosim Medical Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Imunosim Medical Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Imunosim Medical Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Imunosim Medical Srl - CUI 30049332
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
0
0
0
0
685
568
Current Assets
37
37
4.653
14.200
39.558
14.651
35.549
18.279
21.118
9.012
Inventories
0
0
4.484
1.478
471
1.344
792
991
2.583
3.229
Receivables
0
0
0
0
131
0
24.916
0
1.255
509
Cash
37
37
169
12.722
38.956
13.307
9.841
17.288
17.280
5.274
Shareholders Funds
-784
-587
-575
11.182
37.385
19.248
37.783
17.597
18.612
50
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
821
624
5.228
3.018
2.173
2.646
5.984
9.509
11.112
9.529
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4727 - 4727"
CAEN Financial Year
4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
9.012 euro in 2024 which includes Inventories of
3.229 euro, Receivables of
509 euro and cash availability of
5.274 euro.
The company's Equity was valued at
50 euro, while total Liabilities amounted to
9.529 euro.
Equity decreased by -18.458 euro, from 18.612 euro in 2023, to 50 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Imunosim Medical Srl